Skip to content

Evaluation of the effect of fentanyl or sulfentanil on spinal anesthesia in cesarean section

Comparison the effect of composition of fentanyl or interathecal suffentanil with 0.5 hyperbaric bupivacaine in spinal anesthesia in elective cesarean patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171109037340N1
Enrollment
90
Registered
2018-03-10
Start date
2017-02-08
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section. Onset (spontaneous) of labor after 37 completed weeks of gestation but before 39 completed weeks gestation, with delivery by (planned) cesarean section

Interventions

Intervention 1: First intervention group: receiving 20 µg fentanyl plus 0.5% hyperbaric bupivacaine. Intervention 2: Second intervention group: receveing 5.2 µg sufentanil plus 0.5% hyperbaric bupivac

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Term pregnancy Primigravida ASA class 1 and 2 Cesarean section due to cephalopelvic disproportion

Exclusion criteria

Exclusion criteria: spinal anesthesia contraindication Gestational hypertension Gestational diabetes Placenta previa

Design outcomes

Primary

MeasureTime frame
Analgesia quality. Timepoint: Immediately after drug injection. Method of measurement: Based on 4 grades; Excellent: During the procedure, patients feel comfortable with no complainment. Good: brief discomfort with no need of additional medication. Moderate: Unpleasant but controllable with additional medication such as phenthanyl, propofol, dormicom and the like. Poor: Inability to control even with an additional drug.;The duration of effective analgesia. Timepoint: The interval between the initiation of drug administration in each group until the first request of analgesia by patients. Method of measurement: 1-awake and anxious; 2- awake and calm; 3- sleepy but easily awake; 4- sleepy but not easily awake.;Duration of discharge. Timepoint: The interval between the initiation of drug administration in each group until the time of discharge from hospital. Method of measurement: Day.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Arefpour

Zahedan University of Medical Sciences

Dr.arefpour@zaums.ac.ir+98 54 3329 5744

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026